# Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI

> **NCT06564909** · PHASE2 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 76 (estimated)

## Conditions studied

- Reperfusion Injury, Myocardial
- Myocardial Infarction

## Interventions

- **DRUG:** L-Carnitine
- **DRUG:** The standard care for the management of myocardial infarction post PCI

## Key facts

- **NCT ID:** NCT06564909
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-02
- **Final completion:** 2026-03
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06564909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06564909, "Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06564909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*